Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Aug;133(3):286-294.
doi: 10.1038/s41416-025-03055-9. Epub 2025 May 20.

Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin

Affiliations
Comparative Study

Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin

Roope A Kallionpää et al. Br J Cancer. 2025 Aug.

Abstract

Background: Cutaneous neurofibromas (cNFs) are the hallmark of the tumor-predisposition syndrome neurofibromatosis 1 (NF1). While cNFs are always benign, they markedly decrease quality of life in individuals with NF1. Understanding the differences between cNFs and the skin is essential for developing treatments for cNFs.

Methods: We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene Ontology (GO) terms.

Results: The expression patterns of the Schwann cell marker S100B and several keratins confirmed successful dissection of cNF tissue from the overlying skin. Hierarchical clustering showed extensive overlap between the tumor and skin samples in three out of four individuals, suggesting high overall similarity between the two tissue types. Based on the analysis of the GO terms, cNFs were associated with decreased expression of proteins related to cell proliferation, extracellular matrix remodeling, angiogenesis and cellular metabolism.

Conclusion: The cNFs are relatively quiescent, consistent with their benign nature and limited growth potential. The development of pharmacological therapy for cNFs requires overcoming the high similarity between cNFs and the overlying skin. The present dataset can serve as a resource for future research on cNFs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The study adhered to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the Hospital District of Southwest Finland (131/1803/2017), and Turku University Hospital. All participants provided their written informed consent.

Figures

Fig. 1
Fig. 1. Hierarchical clustering of cutaneous neurofibromas and the overlying skin based on protein quantities.
The top row shows results of individual-wise clustering, and the bottom panel displays pooled clustering of all the samples. In the dendrograms, tumor samples are highlighted in blue, and skin samples in orange. In the lower panel, each individual is denoted with a unique symbol in the dendrogram.
Fig. 2
Fig. 2. Hematoxylin-eosin staining and immunohistochemical labeling for the cell proliferation marker Ki67, and collagens XV (ColXV) and XVIII (ColXVIII) of a representative cutaneous neurofibroma.
A total of 20 cutaneous neurofibromas from seven NF1 patients were examined. Proliferating cells are sparse within the tumor compared with the overlying skin whereas ColXV and ColXVIII are predominantly expressed in the tumor tissue. Scale bars 1 mm in the first column, 200 µm in the second column.

Similar articles

References

    1. Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Prim. 2017;3:17004. - PubMed
    1. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178:1932–9. - PMC - PubMed
    1. Easton DF, Ponder MA, Huson SM, Ponder BA. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet. 1993;53:305–13. - PMC - PubMed
    1. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608–14. - PubMed
    1. Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P. Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients. Dermatology. 2011;222:269–73. - PubMed

Publication types

Substances